Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2023, 32(2):77-81

Comment on 2022 ESC Guidelines on cardio-oncology

Slanina M
LL.M., Kardiocentrum, Kardiologická klinika PU, FNsP J. A. Reimana Prešov, Jána Hollého 14, 080 01 Prešov, Slovenská republika

Published: February 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slanina M. Comment on 2022 ESC Guidelines on cardio-oncology. Cardiology Letters. 2023;32(2):77-81.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of anticancer treatments epidemiology, detection, and management. CA Cancer J. Clin 2016;66:309-325. Go to original source...
    2. Zamorano JL, Lancellotti P, Muñoz DR, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768-2801. Go to original source...
    3. Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics. 2021. CA Cancer J Clin 2021;71:7-33. Go to original source...
    4. Oeffinger KC, Mertens AC, Sklar CA, et al. Childhood Cancer Survival Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582. Go to original source...
    5. Khouri MG, Douglas PS, Mackey JR, et al. Cancer therapyinduced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation 2012;126:2749-2763. Go to original source...
    6. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin; a retrospective analysis of three trials. Cancer 2003;97:2869-2879. Go to original source...
    7. Lenihan DJ, Stevens PL, Massey M, et al. The utility of point-ofcare biomarkers to detect cardiotoxicity during anthracycline chemotherapy: a feasibility study. J Card Fail 2016;22:433-438. Go to original source...
    8. Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 2014;63:2751-2768. Go to original source...
    9. Field JJ, Kanakkanthara A, Miller JH. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. Bioorg Med Chem 2014;22:5050-5059. Go to original source...
    10. Heck SL, Mecinaj A, Ree AH, et al. Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): a 2x2 factorial, randomized, placebo-controlled, doubleblind clinical trial of candesartan and metoprolol. Circulation 2021;143:2431-2440. Go to original source...
    11. Ridker PM. Clinician's guide to reducing inflammation to reduce atherothrombotic risk: JACC review topic of the week. J Am Coll Cardiol 2018;72:3320-3321. Go to original source...
    12. Javaid AI, Monlezun DJ, Iliescu G, et al. Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy thype. ESC Heart Fail 2021;8:46264234. Go to original source...
    13. Bottinor WJ, Shuey MM, Manouchehri A, et al. Reninangiotensin-aldosterone system modulates blood pressure response during vascular endothelial growth factor receptor inhibition. JACC CardioOncol 2019;1:14-23. Go to original source...

    Return to the content